Houston biotech cos. begin clinical trials for cancer, Covid-19 treatments
October 20, 2021 at 17:46 PM EDT
Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |